Cargando…
Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018303/ https://www.ncbi.nlm.nih.gov/pubmed/36789579 http://dx.doi.org/10.5009/gnl220522 |
| _version_ | 1784907780883218432 |
|---|---|
| author | Yim, Hyung Joon Ahn, Young Eun Kim, Tae Hyung Jung, Young Kul |
| author_facet | Yim, Hyung Joon Ahn, Young Eun Kim, Tae Hyung Jung, Young Kul |
| author_sort | Yim, Hyung Joon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10018303 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100183032023-03-17 Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply Yim, Hyung Joon Ahn, Young Eun Kim, Tae Hyung Jung, Young Kul Gut Liver Aop Editorial Office of Gut and Liver 2023-03-15 2023-02-15 /pmc/articles/PMC10018303/ /pubmed/36789579 http://dx.doi.org/10.5009/gnl220522 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Aop Yim, Hyung Joon Ahn, Young Eun Kim, Tae Hyung Jung, Young Kul Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply |
| title | Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply |
| title_full | Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply |
| title_fullStr | Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply |
| title_full_unstemmed | Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply |
| title_short | Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply |
| title_sort | comments on comparison of sorafenib versus hepatic arterial infusion chemotherapy-based treatment for advanced hepatocellular carcinoma with portal vein tumor thrombosis: reply |
| topic | Aop |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018303/ https://www.ncbi.nlm.nih.gov/pubmed/36789579 http://dx.doi.org/10.5009/gnl220522 |
| work_keys_str_mv | AT yimhyungjoon commentsoncomparisonofsorafenibversushepaticarterialinfusionchemotherapybasedtreatmentforadvancedhepatocellularcarcinomawithportalveintumorthrombosisreply AT ahnyoungeun commentsoncomparisonofsorafenibversushepaticarterialinfusionchemotherapybasedtreatmentforadvancedhepatocellularcarcinomawithportalveintumorthrombosisreply AT kimtaehyung commentsoncomparisonofsorafenibversushepaticarterialinfusionchemotherapybasedtreatmentforadvancedhepatocellularcarcinomawithportalveintumorthrombosisreply AT jungyoungkul commentsoncomparisonofsorafenibversushepaticarterialinfusionchemotherapybasedtreatmentforadvancedhepatocellularcarcinomawithportalveintumorthrombosisreply |